Is this you? Create Your Porfile
Avatar

Gabriele Winter

Bayer HealthCare Pharmaceuticals

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Gabriele Winter is active.

Explore More

Publication

Featured researches published by Gabriele Winter.

Biospektrum | 2012

Partikel und Aggregate in Proteinformulierungen

Carsten Olbrich; Gabriele Winter

Protein aggregates may be a challenge for the development of safe and effective protein therapeutics. Novel analytical methods are now available to monitor the critical size range of 0.1 to 10 μm for subvisible particles and allow optimization of protein drug formulations and manufacturing conditions. Monitoring of this particle class may also allow a potential correlation of side effects seen in the clinical development and protein aggregates.

Archive | 2001

Novel solid body forms of mesoprogestin 11beta-{4e-(hydroxyiminomethyl)-phenyl}-17alpha methoxymethyl-17 beta-methoxy-estra-4,9-dien-3-one

Detlef Grawe; Peter Hösel; Uwe Müller; Gabriele Winter

Archive | 2006

Crystalline 11beta-(4-acetylphenyl)-20,20,21,21,21-pentafluor-17-hydroxy-19-nor-17alpha-pregna-4,9-dien-3-one

Wolfgang Beckmann; Gabriele Winter; Edda. Dr Krämer; Thomas Ginko; Evelin. Dr Amoulong

Archive | 2011

Crystalline potassium salt of lipoxin A4 analogs

Tilo Haag; Danja Grossbach; Gabriele Winter; Michael Sander; Wolfgang Beckmann; Klaus Bartel; Christian Dinter

Archive | 2001

New solid forms of mesoprogestin 11Beta-[4E-(hydroxyimino methyl)-phenyl]-17alpha-methoxymethyl-17beta-methoxy-estra-4,9-dien-3-on

Detlef Grawe; Peter Hösel; Uwe Müller; Gabriele Winter

Archive | 2016

Pharmaceutical dosage forms containing sodium-1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1h-1,2,3-triazol-1-yl)-1h-pyrazol-5-olate

Heike Neumann; Klaus Benke; Michael Formell; Gabriele Winter

Archive | 2016

COMPOSICIONES FARMACÉUTICAS QUE CONTIENEN REFAMETINIB, USO Y MÉTODO DE TRATAMIENTO

Anke Stroyer; Susanne Skrabs; Michael Formel; Gabriele Winter; Rosemarie Dr Kissenbeck

Archive | 2015

FORMAS FARMACÉUTICAS DE DOSIFICACIÓN QUE COMPRENDEN 1-[6-(MORFOLIN-4-IL)PIRIMIDIN-4-IL]-4-(1H-1,2,3-TRIAZOL-1-IL)-1H-PIRAZOL-5-OLATO DE SODIO

Heike Neumann; Klaus Benke; Michael Formell; Gabriele Winter

Archive | 2014

Compositions pharmaceutiques contenant du réfamétinib

Anke Stroyer; Susanne Skrabs; Michael Formell; Gabriele Winter; Rosemarie Kissenbeck

Archive | 2011

ANHYDROUS AND HYDRATE FORMS OF CRYSTALLINE 2- ( (2S, 3R, 4E, 6E, 1OE, 12S) -13- (4-FLUOROPHENOXY) -2,3, 12- (TRIHYDROXYTRIDECA-4, 6, 10-TRIEN-8-YNYL) OXY) ACETIC ACID

Klaus Bartel; Danja Grossbach; William J. Guilford; Michael Sander; Gabriele Winter

Explore More

Collaboration

Dive into the Gabriele Winter's collaboration.

Top Co-Authors
Avatar

Detlef Grawe

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Danja Grossbach

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Klaus Bartel

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Michael Formell

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Michael Sander

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Peter Hösel

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Uwe Müller

Henkel

View shared research outputs
Top Co-Authors
Avatar

Anke Stroyer

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Heike Neumann

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Klaus Benke

Bayer HealthCare Pharmaceuticals

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge